DBV Technologies Announces Appointment of Michel de Rosen

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
25
DBV Technologies Announces Appointment of Michel de Rosen to its Board of Directors
Montrouge, France, May 16, 2018

DBV Technologies Announces Appointment of Michel de Rosen to its Board of Directors

DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Michel de Rosen has been appointed to the Company's Board of Directors, in replacement of George Horner III. Michel de Rosen's appointment will be proposed at the Company's Ordinary and Extraordinary General Meeting on June 22, 2018, in Montrouge, France. With this addition, DBV's Board now comprises eight directors.

Dr. Pierre-Henri Benhamou , Chairman & Chief Executive Officer of DBV Technologies, said: "It is with great pleasure that we welcome Michel to DBV. We believe his extensive business experience in the biopharmaceutical industry, with 15 years spent in the US, will continue strengthening our team, and that his advice will be instrumental as we move closer to bringing potential treatments to patients suffering from peanut allergy and other diseases."

Michel de Rosen is currently Chairman of the Board of Faurecia, a global supplier of automotive equipment and Chairman of the Board of Pharnext, a publicly-traded innovative pharmaceutical company. Previously, he served as Chairman and Chief Executive Officer of Eutelsat, Chairman and Chief Executive Officer of ViroPharma and Chairman and Chief Executive Officer of Rhône-Poulenc Santé. Earlier in his career, Michel de Rosen held key positions at the French Ministries of Finance, Defense, Industry, and Telecommunications.

"I am thrilled to join the Board of DBV at this crucial time for the Company and look forward to working closely with the Board and management team," said Michel de Rosen . "I am excited to contribute to the progress of this innovative company, notably in light of the potential approval and subsequent launch of Viaskin Peanut, its first product candidate."

About DBV Technologies 

DBV Technologies is developing Viaskin®, a proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT®, DBV's method of delivering biologically active compounds to the immune system through intact skin. With this new class of self-administered and non-invasive product candidates, the Company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments. DBV's food allergies programs include ongoing clinical trials of Viaskin Peanut and Viaskin Milk, and preclinical development of Viaskin Egg. DBV is also pursuing a human proof-of-concept clinical study of Viaskin Milk for the treatment of Eosinophilic Esophagitis, and exploring potential applications of its platform in vaccines and other immune diseases. DBV Technologies has global headquarters in Montrouge, France and New York, NY. The Company's ordinary shares are traded on segment A of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), part of the SBF120 index, and the Company's ADSs (each representing one-half of one ordinary share) are traded on the Nasdaq Global Select Market (Ticker: DBVT).

Contact Sara Blum Sherman Senior Director, Investor Relations & Strategy +1 212-271-0740 sara.sherman@dbv-technologies.com

DBV Media Contact Raul Damas Partner, Brunswick Group +1-212-333-3810 DBV@brunswickgroup.com

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 10

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 9

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 24

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 5

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 14

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 11

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 10

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 18

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 7

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 13

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading

Top 5 Most Recently Viewed Articles

Lowe's Reverses Diversity Policies Amid Activist Pressure

Updated Category News Views 175

Lowe's Reassesses Its Diversity Initiatives Lowe’s has decided to reduce some of its diversity initiatives, marking a notable change among large corporations as they respond to growing activist pressures. Employee Communication and Cancellations The home improvement giant recently informed its employees that it would stop participating in diversity surveys from LGBTQ...

Continue Reading
Pavel Durov Accuses French Intelligence of Political Pressure

Updated Category News Views 249

Pavel Durov's Bold Allegations Against French Intelligence Pavel Durov, the billionaire founder of Telegram, recently stirred controversy by alleging that French intelligence attempted to pressure him into censorship of Moldovan channels on his platform. This claim arose amidst ongoing legal challenges he faces in France. Censorship Demands During Moldovan Elections Durov...

Continue Reading
Processa Pharmaceuticals Unveils $7 Million Public Offering Details

Updated Category News Views 237

Processa Pharmaceuticals Announces Share Offering Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), a visionary company dedicated to the advancement of Next Generation Cancer (NGC) therapies, has officially priced a significant public offering. This strategic move entails issuing 28,000,000 shares of its common stock, accompanied by warrants allowing for the purchase of an...

Continue Reading
Xellar's $50M Series A: A Leap in 3D Bio-Tech

Updated Category News Views 5

Crunching the Numbers in Biotech's New Frontier Well, here's a tale of ambition and cash that would make your head spin, even if you've seen as many market stunts as I have. Xellar Biosystems pulled off a stunner by bagging a fresh $50 million in Series A and A+ financing. It's a bold move, no two ways about it, as they aim to carve out a niche in the complex world of...

Continue Reading
Taiwan's Automotive Industry: Bridging Part Shortages with Quality

Updated Category News Views 168

Taiwan's Growing Role in the Automotive Industry As countries around the world grapple with various challenges in the automotive market, Taiwan has emerged as a pivotal player in addressing critical shortages of auto parts. The ongoing demand for reliable automotive components has brought the Taiwanese auto parts industry into the spotlight, demonstrating its capacity to...

Continue Reading